• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制mmu_circ_0009303通过调节脂质代谢和氧化应激改善代谢功能障碍相关脂肪性肝病。

Inhibition of mmu_circ_0009303 improves metabolic dysfunction-associated steatotic liver disease by regulating lipid metabolism and oxidative stress.

作者信息

Zhou Ju, Li Wu, Chi Xiaowei, Li Dingchun, Yang Chunxia, Duan Zhiwen

机构信息

Department of Infectious Disease, The First Affiliated Hospital, Kunming Medical University, Kunming 650032, China.

出版信息

Endocr J. 2025 Jan 6;72(1):79-91. doi: 10.1507/endocrj.EJ24-0008. Epub 2024 Oct 24.

DOI:10.1507/endocrj.EJ24-0008
PMID:39443113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11778371/
Abstract

Circular RNAs (circRNAs) play an important role in regulating inflammation and oxidative stress during the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD); however, the underlying mechanism is unclear. This study aimed to determine the role of mmu_circ_0009303 in MASLD. We used a bioinformatics approach to identify potential targets and established an in vitro model of MASLD. Oil red O staining, cell transfection and dual-luciferase reporter assay were used to determine the role of mmu_circ_0009303. The results indicated that the mmu_circ_0009303 expression was significantly increased in the MASLD model both in vitro and in vivo and was associated with oxidative stress levels and inflammation. Moreover, bioinformatics analyses revealed that miRNA-182-5p and Foxo3 are targets of mmu_circ_0009303 and miRNA-182-5p, respectively. In the in vitro MASLD model, mmu_circ_0009303 promoted fat deposition in NCTC1469 cells, which was induced by free fatty acid (FFA) through the regulation of miRNA-182-5p/Foxo3. The expression of miRNA-182-5p and Forkhead box O3 (Foxo3) was associated with mmu_circ_0009303 expression in the liver of mice with MASLD, which was induced by a high-fat diet. Furthermore, mmu_circ_0009303 may be involved in regulating the expression of lipid metabolism-related regulatory proteins, such as CPT1A, SLC27A4, ACBD3, SREBP1, FAS, PPARα, and PPARγ. Taken together, mmu_circ_0009303 promotes oxidative stress, inflammation, and excessive fat accumulation in NCTC1469 cells induced by FFA through the regulation of miRNA-182-5p/Foxo3 and lipid metabolism-related regulatory proteins. These findings provide a potential target for the treatment of MASLD.

摘要

环状RNA(circRNAs)在代谢功能障碍相关脂肪性肝病(MASLD)发病机制中调节炎症和氧化应激方面发挥重要作用;然而,其潜在机制尚不清楚。本研究旨在确定mmu_circ_0009303在MASLD中的作用。我们采用生物信息学方法识别潜在靶点,并建立了MASLD的体外模型。通过油红O染色、细胞转染和双荧光素酶报告基因检测来确定mmu_circ_0009303的作用。结果表明,mmu_circ_0009303在体外和体内的MASLD模型中表达均显著增加,且与氧化应激水平和炎症相关。此外,生物信息学分析显示,miRNA-182-5p和Foxo3分别是mmu_circ_0009303和miRNA-182-5p的靶点。在体外MASLD模型中,mmu_circ_0009303通过调节miRNA-182-5p/Foxo3促进游离脂肪酸(FFA)诱导的NCTC1469细胞脂肪沉积。miRNA-182-5p和叉头框O3(Foxo3)的表达与高脂饮食诱导的MASLD小鼠肝脏中mmu_circ_0009303的表达相关。此外,mmu_circ_0009303可能参与调节脂质代谢相关调节蛋白的表达,如肉碱棕榈酰转移酶1A(CPT1A)、溶质载体家族27成员4(SLC27A4)、酰基辅酶A结合结构域蛋白3(ACBD3)、固醇调节元件结合蛋白1(SREBP1)、脂肪酸合酶(FAS)、过氧化物酶体增殖物激活受体α(PPARα)和过氧化物酶体增殖物激活受体γ(PPARγ)。综上所述,mmu_circ_0009303通过调节miRNA-182-5p/Foxo3和脂质代谢相关调节蛋白,促进FFA诱导的NCTC1469细胞氧化应激、炎症和过度脂肪积累。这些发现为MASLD的治疗提供了一个潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ba4/11778371/f9a2f423a1f5/72_EJ24-0008_6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ba4/11778371/b05e3c5b37c7/72_EJ24-0008_1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ba4/11778371/4c470bf01628/72_EJ24-0008_2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ba4/11778371/1735d78548a5/72_EJ24-0008_3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ba4/11778371/226af9f1688a/72_EJ24-0008_4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ba4/11778371/429f6e0d2cf9/72_EJ24-0008_5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ba4/11778371/f9a2f423a1f5/72_EJ24-0008_6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ba4/11778371/b05e3c5b37c7/72_EJ24-0008_1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ba4/11778371/4c470bf01628/72_EJ24-0008_2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ba4/11778371/1735d78548a5/72_EJ24-0008_3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ba4/11778371/226af9f1688a/72_EJ24-0008_4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ba4/11778371/429f6e0d2cf9/72_EJ24-0008_5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ba4/11778371/f9a2f423a1f5/72_EJ24-0008_6.jpg

相似文献

1
Inhibition of mmu_circ_0009303 improves metabolic dysfunction-associated steatotic liver disease by regulating lipid metabolism and oxidative stress.抑制mmu_circ_0009303通过调节脂质代谢和氧化应激改善代谢功能障碍相关脂肪性肝病。
Endocr J. 2025 Jan 6;72(1):79-91. doi: 10.1507/endocrj.EJ24-0008. Epub 2024 Oct 24.
2
MicroRNA-411-5p alleviates lipid deposition in metabolic dysfunction-associated steatotic liver disease by targeting the EIF4G2/FOXO3 axis.MicroRNA-411-5p 通过靶向 EIF4G2/FOXO3 轴缓解代谢相关脂肪性肝病中的脂质沉积。
Cell Mol Life Sci. 2024 Sep 11;81(1):398. doi: 10.1007/s00018-024-05434-6.
3
Circular RNA RRM2 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miR-142-5p to increase NRG1 expression.环状 RNA RRM2 通过靶向 miR-142-5p 增加 NRG1 表达来减轻与代谢功能障碍相关的脂肪性肝病。
Am J Physiol Gastrointest Liver Physiol. 2024 Oct 1;327(4):G485-G498. doi: 10.1152/ajpgi.00255.2023. Epub 2024 Jul 23.
4
Rbm39 ameliorates metabolic dysfunction-associated steatotic liver disease by regulating Apob and Fabp4.Rbm39通过调节载脂蛋白B(Apob)和脂肪酸结合蛋白4(Fabp4)改善代谢功能障碍相关的脂肪性肝病。
Biochim Biophys Acta Mol Basis Dis. 2025 Jun;1871(5):167815. doi: 10.1016/j.bbadis.2025.167815. Epub 2025 Mar 26.
5
Caffeic acid ameliorates metabolic dysfunction-associated steatotic liver disease via alleviating oxidative damage and lipid accumulation in hepatocytes through activating Nrf2 via targeting Keap1.咖啡酸通过靶向 Keap1 激活 Nrf2 减轻肝细胞氧化损伤和脂质堆积来改善代谢相关脂肪性肝病。
Free Radic Biol Med. 2024 Nov 1;224:352-365. doi: 10.1016/j.freeradbiomed.2024.08.038. Epub 2024 Aug 28.
6
Oxidative stress-induced circSOD2 inhibits osteogenesis through sponging miR-29b in metabolic-associated fatty liver disease.氧化应激诱导的环状超氧化物歧化酶2通过海绵吸附代谢相关脂肪性肝病中的miR-29b抑制成骨作用。
World J Gastroenterol. 2025 Mar 7;31(9):98027. doi: 10.3748/wjg.v31.i9.98027.
7
Circular RNA hsa_circ_0001368 suppresses the progression of gastric cancer by regulating miR-6506-5p/FOXO3 axis.环状 RNA hsa_circ_0001368 通过调控 miR-6506-5p/FOXO3 轴抑制胃癌进展。
Biochem Biophys Res Commun. 2019 Apr 23;512(1):29-33. doi: 10.1016/j.bbrc.2019.02.111. Epub 2019 Mar 7.
8
Artemisia capillaris Thunb. Water extract alleviates metabolic dysfunction-associated Steatotic liver disease Disease by inhibiting miR-34a-5p to activate Sirt1-mediated hepatic lipid metabolism.茵陈蒿水提取物通过抑制miR-34a-5p激活Sirt1介导的肝脏脂质代谢来减轻代谢功能障碍相关的脂肪性肝病。
J Ethnopharmacol. 2025 Feb 10;338(Pt 2):119030. doi: 10.1016/j.jep.2024.119030. Epub 2024 Nov 6.
9
NORAD exacerbates metabolic dysfunction-associated steatotic liver disease development via the miR-511-3p/Rock2 axis and inhibits ubiquitin-mediated degradation of ROCK2.去甲肾上腺素通过miR-511-3p/Rock2轴加剧代谢功能障碍相关脂肪性肝病的发展,并抑制泛素介导的ROCK2降解。
Metabolism. 2025 Mar;164:156111. doi: 10.1016/j.metabol.2024.156111. Epub 2024 Dec 20.
10
The Extract of Camellia Seed Cake Alleviates Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Mice by Promoting Coenzyme Q Synthesis.茶籽饼提取物通过促进辅酶Q合成减轻小鼠代谢功能障碍相关脂肪性肝病(MASLD)
Nutrients. 2025 Mar 15;17(6):1032. doi: 10.3390/nu17061032.

引用本文的文献

1
CircDock6 drives metabolic dysfunction-associated steatotic liver disease progression in mice and mouse hepatocytes via mmu-let-7g-5p/insulin-like growth factor 1 receptor regulation.环状RNA Dock6通过调控小鼠微小RNA-let-7g-5p/胰岛素样生长因子1受体,驱动小鼠和小鼠肝细胞中与代谢功能障碍相关的脂肪性肝病进展。
J Int Med Res. 2025 Aug;53(8):3000605251362984. doi: 10.1177/03000605251362984. Epub 2025 Aug 12.

本文引用的文献

1
The Hsa_circ_0105558/miR-182-5p/ATF6 Cascade Affects HO-Triggered Oxidative Damage and Apoptosis of Human Lens Epithelial Cells.Hsa_circ_0105558/miR-182-5p/ATF6 级联反应影响过氧化氢诱导的人晶状体上皮细胞氧化损伤和凋亡。
Biochem Genet. 2025 Apr;63(2):1241-1257. doi: 10.1007/s10528-024-10753-1. Epub 2024 Mar 26.
2
Circ_0003570 Suppresses the progression of hepatocellular carcinoma through miR-182-5p/STARD13 regulatory axis.Circ_0003570通过miR-182-5p/STARD13调控轴抑制肝细胞癌进展。
Biol Proced Online. 2022 Oct 14;24(1):14. doi: 10.1186/s12575-022-00176-w.
3
miR-182-5p promotes hepatocyte-stellate cell crosstalk to facilitate liver regeneration.
miR-182-5p 促进肝细胞-星状细胞串扰促进肝再生。
Commun Biol. 2022 Aug 1;5(1):771. doi: 10.1038/s42003-022-03714-0.
4
Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers.代谢相关脂肪性肝病与 24 种特定癌症风险的关系。
Metabolism. 2022 Feb;127:154955. doi: 10.1016/j.metabol.2021.154955. Epub 2021 Dec 14.
5
Hsa_circ_0048179 attenuates free fatty acid-induced steatosis via hsa_circ_0048179/miR-188-3p/GPX4 signaling.Hsa_circ_0048179 通过 hsa_circ_0048179/miR-188-3p/GPX4 信号通路减轻游离脂肪酸诱导的脂肪变性。
Aging (Albany NY). 2020 Nov 18;12(23):23996-24008. doi: 10.18632/aging.104081.
6
Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort.经活检证实的非酒精性脂肪性肝病的死亡率:一项全国性队列研究的结果。
Gut. 2021 Jul;70(7):1375-1382. doi: 10.1136/gutjnl-2020-322786. Epub 2020 Oct 9.
7
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Clin Med (Lond). 2020 Sep;20(5):509-512. doi: 10.7861/clinmed.2020-0696.
8
Circ_002664/miR-182-5p/Herpud1 pathway importantly contributes to OGD/R-induced neuronal cell apoptosis.Circ_002664/miR-182-5p/Herpud1 通路对 OGD/R 诱导的神经元细胞凋亡有重要贡献。
Mol Cell Probes. 2020 Oct;53:101585. doi: 10.1016/j.mcp.2020.101585. Epub 2020 May 4.
9
Epigenetic silencing of microRNA-125b-5p promotes liver fibrosis in nonalcoholic fatty liver disease via integrin α8-mediated activation of RhoA signaling pathway.miRNA-125b-5p 的表观遗传沉默通过整合素 α8 介导的 RhoA 信号通路激活促进非酒精性脂肪性肝病肝纤维化。
Metabolism. 2020 Mar;104:154140. doi: 10.1016/j.metabol.2020.154140. Epub 2020 Jan 9.
10
CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential.CPT1A 介导的脂肪氧化:机制与治疗潜力。
Endocrinology. 2020 Feb 1;161(2). doi: 10.1210/endocr/bqz046.